2,102 HCA Healthcare, Inc. $HCA Shares Bought by Decker Wealth Management LLC

Decker Wealth Management LLC grew its position in HCA Healthcare, Inc. (NYSE:HCA) by 13.7% in the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 17,460 shares of the company’s stock after buying an additional 2,102 shares during the period. HCA Healthcare makes up about 1.5% of Decker Wealth Management LLC’s investment portfolio, making the stock its 23rd largest holding. Decker Wealth Management LLC’s holdings in HCA Healthcare were worth $7,451,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Wedmont Private Capital boosted its holdings in shares of HCA Healthcare by 7.3% during the 3rd quarter. Wedmont Private Capital now owns 3,754 shares of the company’s stock valued at $1,671,000 after acquiring an additional 256 shares during the last quarter. Monument Capital Management grew its position in HCA Healthcare by 7.0% in the 3rd quarter. Monument Capital Management now owns 672 shares of the company’s stock worth $287,000 after purchasing an additional 44 shares during the period. GAMMA Investing LLC lifted its holdings in shares of HCA Healthcare by 14.9% during the 3rd quarter. GAMMA Investing LLC now owns 4,575 shares of the company’s stock valued at $1,952,000 after buying an additional 593 shares during the period. Farther Finance Advisors LLC increased its position in HCA Healthcare by 5.9% during the third quarter. Farther Finance Advisors LLC now owns 4,881 shares of the company’s stock valued at $2,083,000 after acquiring an additional 271 shares during the last quarter. Finally, CoreCap Advisors LLC increased its position in shares of HCA Healthcare by 184.0% during the 3rd quarter. CoreCap Advisors LLC now owns 230 shares of the company’s stock valued at $98,000 after purchasing an additional 149 shares during the last quarter. 62.73% of the stock is owned by institutional investors.

HCA Healthcare Trading Up 1.3%

HCA traded up $5.71 on Friday, hitting $450.72. 980,841 shares of the company’s stock traded hands, compared to its average volume of 1,344,523. HCA Healthcare, Inc. has a one year low of $353.99 and a one year high of $556.52. The company’s 50 day simple moving average is $419.88 and its 200-day simple moving average is $419.76. The firm has a market cap of $97.58 billion, a price-to-earnings ratio of 15.09, a P/E/G ratio of 1.48 and a beta of 1.10.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings data on Friday, July 24th. The company reported $7.59 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.56 by $0.03. HCA Healthcare had a net margin of 8.77% and a negative return on equity of 244.79%. The firm had revenue of $20.23 billion for the quarter, compared to analysts’ expectations of $19.76 billion. During the same quarter last year, the business posted $6.84 earnings per share. The company’s revenue for the quarter was up 8.7% compared to the same quarter last year. As a group, equities analysts anticipate that HCA Healthcare, Inc. will post 29.42 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, September 30th. Stockholders of record on Wednesday, September 16th were given a dividend of $0.78 per share. The ex-dividend date was Wednesday, September 16th. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.7%. HCA Healthcare’s dividend payout ratio (DPR) is presently 10.45%.

Analyst Upgrades and Downgrades

A number of brokerages have commented on HCA. BMO Capital Markets began coverage on shares of HCA Healthcare in a report on Tuesday, September 22nd. They set an “outperform” rating and a $495.00 target price for the company. The Goldman Sachs Group lowered their target price on HCA Healthcare from $558.00 to $485.00 and set a “buy” rating on the stock in a research report on Tuesday, July 28th. Royal Bank Of Canada raised their price objective on HCA Healthcare from $435.00 to $496.00 and gave the stock an “outperform” rating in a research note on Wednesday. TD Cowen reduced their target price on shares of HCA Healthcare from $500.00 to $431.00 and set a “buy” rating for the company in a report on Monday, June 22nd. Finally, Raymond James Financial set a $528.00 price target on shares of HCA Healthcare in a research report on Tuesday, July 7th. Sixteen research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, HCA Healthcare currently has an average rating of “Moderate Buy” and an average price target of $466.35.

HCA Healthcare Company Profile

HCA Healthcare, Inc is a provider of healthcare services in the United States. Through its network of hospitals and other healthcare facilities, the company delivers services including emergency and urgent care, surgery, inpatient and outpatient treatment, women’s and children’s care, cardiology, oncology, orthopedics, and behavioral health services.

HCA Healthcare also operates physician practices, ambulatory surgery centers, freestanding emergency rooms, diagnostic facilities, and other outpatient care sites.